Emergent Biosolutions Inc (EBS)
SG&A Expenses
$44.60M
Quarterly · Period ending: · USD
EBS SG&A Expenses
Latest reported$44.60Mperiod ending
Latest reported$44.60Mperiod ending
EBS Quarterly SG&A Expenses ($94.20M → $44.60M)
Quarterly SG&A Expenses
High-resolution chart · PNG
EBS sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 44,600,000 | |
| 46,600,000 | |
| 51,100,000 | |
| 38,800,000 | |
| 44,000,000 | |
| 52,700,000 | |
| 60,700,000 | |
| 75,900,000 | |
| 77,300,000 | |
| 84,800,000 | |
| 89,400,000 | |
| 79,700,000 | |
| 91,300,000 | |
| 96,300,000 | |
| 93,400,000 | |
| 81,800,000 | |
| 79,500,000 | |
| 84,800,000 | |
| 94,200,000 | |
| 82,100,000 | |
| 91,200,000 | |
| 80,900,000 | |
| 82,100,000 | |
| 75,500,000 | |
| 76,000,000 | |
| 69,700,000 | |
| 72,200,000 | |
| 65,000,000 | |
| 70,800,000 | |
| 65,400,000 | |
| 76,200,000 | |
| 42,100,000 | |
| 39,500,000 | |
| 40,000,000 | |
| 41,379,000 | |
| 34,503,000 | |
| 31,868,000 | |
| 35,150,000 | |
| 29,421,000 | |
| 36,939,000 | |
| 35,925,000 | |
| 31,713,000 | |
| 34,882,000 | |
| 25,800,000 | |
| 26,270,000 | |
| 34,193,000 | |
| 23,805,000 | |
| 30,292,000 | |
| 30,555,000 | |
| 30,089,000 | |
| 18,121,000 | |
| 21,955,000 | |
| 20,501,000 | |
| 20,028,000 | |
| 19,476,000 | |
| 19,155,000 | |
| 17,895,000 | |
| 19,492,000 | |
| 18,254,000 | |
| 17,432,000 | |
| 20,384,000 | |
| 18,212,000 | |
| 21,671,000 | |
| 20,693,000 | |
| 17,649,000 | |
| 16,192,000 | |
| 18,671,000 | |
| 19,767,000 | |
| 19,373,000 | |
| 15,975,000 | |
| 13,864,000 | |
| 14,115,000 | |
| 15,039,000 | |
| 12,060,000 | |
| 16,666,000 | |
| 15,038,000 | |
| 12,659,000 | |
| 11,193,000 | |
| 11,649,000 | |
| 10,984,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 94,200,000 | |
| 82,100,000 | |
| 91,400,000 | |
| 84,800,000 | |
| 94,200,000 |